Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. Aspirin

   United Therapeutics Europe Ltd

   Node Positive HER2 Negative Breast Cancer

   phase 3 · small molecule · terminated

   1 trial →

2. Atezolizumab

   Hoffmann-La Roche

   Urothelial Carcinoma

   phase 3 · small molecule · completed

   2 trials →

3. Atezolizumab

   Hoffmann-La Roche

   Melanoma

   phase 3 · small molecule · completed

   1 trial →

4. Atezolizumab

   Hoffmann-La Roche

   Carcinoma, Hepatocellular

   phase 3 · small molecule · active

   1 trial →

5. Atezolizumab

   Jazz Pharmaceuticals Ireland Limited

   Small-Cell Lung Cancer

   phase 3 · small molecule · active

   1 trial →

6. Atezolizumab

   Hoffmann-La Roche

   Breast Cancer

   phase 3 · small molecule · completed

   1 trial →

7. Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC)

   LISATA THERAPEUTICS, INC.

   Stage IV Melanoma

   phase 3 · mab · terminated

   1 trial →

8. Avelumab

   Serono Europe Limited

   First Line Non-Small Cell Lung Cancer

   phase 3 · small molecule · completed

   1 trial →

9. Azacitidine Combined With Venetoclax and ATRA group

   The First People's Hospital of Lianyungang

   Acute Myeloid Leukemia

   phase 3 · small molecule · active

   1 trial →

10. B013+Nab-Paclitaxel

    BRIGHT MINDS BIOSCIENCES INC.

    Triple Negative Breast Cancer (TNBC)

    phase 3 · small molecule · completed

    1 trial →

11. B9991046

    Pfizer Australia Pty Ltd

    Cancer

    phase 3 · small molecule · active

    1 trial →

12. BAY 1841788, TRIPTORELIN

    Ningbo Cancer Hospital

    Patients with localised prostate cancer and high-risk features of relapse (minimum 2 high-risk criteria from National Comprehensive Cancer Network (NCCN) classification)1 and with no detectable metastasis, including no evidence of pelvic lymph node metastasis on next-generation imaging (PSMA PET/CT).

    phase 3 · small molecule · active

    1 trial →

13. BAY 3427080, BAY 3427080 60 mg capsules placebo

    Bayer AG

    Vasomotor symptoms caused by adjuvant endocrine therapy in women with, or at high risk for developing hormone-receptor positive breast cancer

    phase 3 · small molecule · active

    1 trial →

14. BCA101X301

    Bicara Therapeutics

    Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

    phase 3 · small molecule · active

    1 trial →

15. BEATcc

    Ningbo Cancer Hospital

    Metastatic (stage IVB), Persistent, or Recurrent Carcinoma of the Cervix

    phase 3 · small molecule · active

    1 trial →

16. BEP(500)

    United Therapeutics Europe Ltd

    Stage I Testicular Non-Seminomatous Germ Cell Tumor

    phase 3 · small molecule · completed

    1 trial →

17. BEVACIZUMAB, ERLOTINIB

    Fondazione Telethon ETS

    Non-squamous Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

18. BGB-11417 for Previously Untreated Chronic Lymphocytic Leukemia

    BEONE MEDICINES AUS PTY LTD

    Previously Untreated Chronic Lymphocytic Leukemia

    phase 3 · small molecule · active

    1 trial →

19. BGB-11417-302

    BEONE MEDICINES AUS PTY LTD

    relapsed or refractory mantle cell lymphoma (R/R MCL)

    phase 3 · small molecule · active

    1 trial →

20. BGB-11417-303CLL-RR1

    BEONE MEDICINES AUS PTY LTD

    Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 3 · small molecule · active

    1 trial →

21. BGB-11417-304

    BEONE MEDICINES AUS PTY LTD

    treatment-naive Chronic Lymphocytic Leukemia

    phase 3 · small molecule · active

    1 trial →

22. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    Chronic Lymphocytic Leukemia

    phase 3 · small molecule · active

    2 trials →

23. BGB-16673-302

    BEONE MEDICINES AUS PTY LTD

    Chronic lymphotic leukemia and Small Lymphocytic lymphoma

    phase 3 · small molecule · active

    1 trial →

24. BGB-16673-304

    BEONE MEDICINES AUS PTY LTD

    Chronic lymphocytic leukemia (CLL), Small lymphocytic lymphoma (SLL)

    phase 3 · small molecule · active

    1 trial →

25. BGB-3111-304

    BEONE MEDICINES AUS PTY LTD

    Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    phase 3 · small molecule · active

    1 trial →

26. BGB-3111-306

    BEONE MEDICINES AUS PTY LTD

    Mantle Cell Lymphoma

    phase 3 · small molecule · active

    1 trial →

27. BGB-43395

    BEONE MEDICINES AUS PTY LTD

    HR+/HER2- Breast Cancer

    phase 3 · small molecule · active

    1 trial →

28. BGB-A317-290-LTE1

    BEONE MEDICINES AUS PTY LTD

    Solid tumors and hamatological malignancies

    phase 3 · small molecule · active

    1 trial →

29. BGB-A317-316

    BEONE MEDICINES AUS PTY LTD

    Locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma

    phase 3 · small molecule · active

    1 trial →

30. BGB-A317-A1217-302

    BeiGene

    Locally advanced, unresectable, or metastatic non small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

31. BGJ398

    BridgeBio Oncology Therapeutics

    Advanced Cholangiocarcinoma

    phase 3 · small molecule · terminated

    1 trial →

32. BNT323-01

    BioNTech SE

    Endometrial cancer

    phase 3 · small molecule · active

    1 trial →

33. BNT327-03

    BioNTech SE

    English First-line extensive-stage small-cell lung cancer (ES-SCLC)

    phase 3 · small molecule · active

    1 trial →

34. BNT327-05

    BioNTech SE

    First line triple-negative breast cancer (TNBC)

    phase 3 · small molecule · active

    1 trial →

35. BNT327-06

    BioNTech SE

    Non-small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

36. BO25323

    Hoffmann-La Roche

    Chronic Lymphocytic Leukemia (CLL)

    phase 3 · small molecule · active

    1 trial →

37. BO28984

    Hoffmann-La Roche

    Anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

38. BO29554

    Hoffmann-La Roche

    Advanced or metastatic Non-small cell lung cancer (NSCLC)

    phase 3 · other · active

    1 trial →

39. BO40336

    Hoffmann-La Roche

    Completely resected, Stage Ib (tumors ≥ 4 cm) to Stage IIIa, Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

40. BO41843

    Hoffmann-La Roche

    ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER

    phase 3 · small molecule · active

    1 trial →

41. BO42592

    Hoffmann-La Roche

    Non-squamous non-small cell lung cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

42. BO42777

    Hoffmann-La Roche

    Non-Small Cell Lung Cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

43. BO42843

    Hoffmann-La Roche

    High-risk muscle-invasive bladder cancer

    phase 3 · small molecule · active

    1 trial →

44. BO42864

    Hoffmann-La Roche

    RET fusion−positive, metastatic Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

45. BO45217

    Hoffmann-La Roche

    KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    phase 3 · other · active

    1 trial →

46. BOOG 2010-02 Stop&Go study

    Teva Pharma GmbH

    Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

    phase 3 · small molecule · completed

    1 trial →

47. BRADI ICO-2023-15

    CERO THERAPEUTICS HOLDINGS, INC.

    Brain metastases of cancer > brain radionecrosis

    phase 3 · small molecule · active

    1 trial →

48. BRCA-P/ABCSG 50

    Shanghai Reinovax Biologics Co.,LTD

    Prevention of breast cancer in women with a BRCA1 germline mutation

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions